[1] |
HA CHUNG B, HORIE S, CHIONG E. The incidence, mortality, and risk factors of prostate cancer in Asian men[J]. Prostate Int,2019,7(1):1-8. doi: 10.1016/j.prnil.2018.11.001 |
[2] |
唐志柳, 白洁, 顾丽娜, 等. 2000-2010年我国前列腺癌和乳腺癌流行状况的系统性综述[J]. 中国肿瘤, 2013, 22(04):260-265. |
[3] |
王宁, 刘硕, 杨雷, 等. 2018全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2019, 5(01):87-97. |
[4] |
ABULA A, SHAO W, TUSONG H, et al. Protein expression information of prostate infection based on data mining[J]. J Infect Public Health,2020,13(10):1533-1536. doi: 10.1016/j.jiph.2019.07.019 |
[5] |
GRÜNERT S C, STUCKI M, MORSCHER R J, et al. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals[J]. Orphanet J Rare Dis,2012,7:31. doi: 10.1186/1750-1172-7-31 |
[6] |
MORSCHER R J, GRÜNERT S C, BÜRER C, et al. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency[J]. Mol Genet Metab,2012,105(4):602-606. doi: 10.1016/j.ymgme.2011.12.018 |
[7] |
HOLZINGER A, RÖSCHINGER W, LAGLER F, et al. Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency[J]. Hum Mol Genet,2001,10(12):1299-1306. doi: 10.1093/hmg/10.12.1299 |
[8] |
GALLARDO M E, DESVIAT L R, RODRÍGUEZ J M, et al. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism[J]. Am J Hum Genet,2001,68(2):334-346. doi: 10.1086/318202 |
[9] |
PANG J, LIU W P, LIU X P, et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis[J]. J Proteome Res,2010,9(1):216-226. doi: 10.1021/pr900953s |
[10] |
MARQUES R B, DITS N F, ERKENS-SCHULZE S, et al. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines[J]. PLoS One,2011,6(8):e23144. doi: 10.1371/journal.pone.0023144 |
[11] |
LIU Y, YUAN Z, SONG C. Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer[J]. Biomarks Med,2019,13(6):427-436. doi: 10.2217/bmm-2018-0475 |
[12] |
JUNG C W, LEE B H, KIM J H, et al. Uneventful clinical courses of Korean patients with methylcrotonylglycinuria and their common mutations[J]. J Hum Genet,2012,57(1):62-64. doi: 10.1038/jhg.2011.116 |
[13] |
AL-SHAMSI A, HERTECANT J L, SOUID A K, et al. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates[J]. Orphanet J Rare Dis,2016,11(1):94. doi: 10.1186/s13023-016-0474-3 |
[14] |
RIPS J, ALMASHANU S, MANDEL H, et al. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program[J]. J Inherit Metab Dis,2016,39(2):211-217. doi: 10.1007/s10545-015-9899-4 |
[15] |
ZANDBERG L, VAN DYK H C, VAN DER WESTHUIZEN F H, et al. A 3-methylcrotonyl-CoA carboxylase deficient human skin fibroblast transcriptome reveals underlying mitochondrial dysfunction and oxidative stress[J]. Int J Biochem Cell Biol,2016,78:116-129. doi: 10.1016/j.biocel.2016.07.010 |
[16] |
FICICIOGLU C, PAYAN I. 3-methylcrotonyl-CoA carboxylase deficiency: metabolic decompensation in a noncompliant child detected through newborn screening[J]. Pediatrics,2006,118(6):2555-2556. doi: 10.1542/peds.2006-1659 |
[17] |
BAUMGARTNER M R, ALMASHANU S, SUORMALA T, et al. The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency[J]. J Clin Invest,2001,107(4):495-504. doi: 10.1172/JCI11948 |
[18] |
STADLER S C, POLANETZ R, MAIER E M, et al. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment[J]. Hum Mutat,2006,27(8):748-759. doi: 10.1002/humu.20349 |
[19] |
YANG L, YANG J, ZHANG T, et al. Identification of eight novel mutations and transcript analysis of two splicing mutations in Chinese newborns with MCC deficiency[J]. Clin Genet,2015,88(5):484-488. doi: 10.1111/cge.12535 |
[20] |
FONSECA H, AZEVEDO L, SERRANO C, et al. 3-methylcrotonyl-CoA carboxylase deficiency: mutational spectrum derived from comprehensive newborn screening[J]. Gene,2016,594(2):203-210. doi: 10.1016/j.gene.2016.09.003 |
[21] |
COZZOLINO C, VILLANI G R, FRISSO G, et al. Biochemical and molecular characterization of 3-methylcrotonylglycinuria in an Italian asymptomatic girl[J]. Genet Mol Biol,2018,41(2):379-385. doi: 10.1590/1678-4685-gmb-2017-0093 |
[22] |
STENSON P D, MORT M, BALL E V, et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine[J]. Hum Genet,2014,133(1):1-9. doi: 10.1007/s00439-013-1358-4 |